← Back
Stock signal

Lear Corp. entra en territorio de sobreventa

Las acciones de Lear Corp. alcanzaron los 103,12 dólares el martes, entrando en territorio de sobreventa con un RSI de 26,8.
By
A monitor displays a stock chart with candlestick patterns and RSI technical indicators.
Foto: Symbolbild | luxalgo.com · Symbolbild (thematisch gesucht: S&P 500 Lear is Oversold) - nicht das Originalfoto der Quelle.
The essentials
  • Las acciones de Lear alcanzaron los 103,12 dólares, el precio más bajo de las últimas operaciones.
  • El RSI de Lear Corp. cayó a 26,8, lo que lo marca como sobrevendido.
  • Los inversores en dividendos ven un rendimiento del 2,80% según el precio reciente de las acciones.

Technical indicators signal a buying opportunity

Lear Corp. (LEA) shares traded as low as $103.12 on Tuesday, a level that has triggered technical indicators. According to the Relative Strength Index, the stock is now in oversold territory, with an RSI of 26.8. This reading suggests potential for a rebound.

The RSI is a tool to assess the momentum of stock price movements. A value below 30 typically signals oversold conditions. The average RSI for the current group of dividend stocks is 48.0, making Lear’s position more notable.

Dividend data offers clues for investors

Despite the drop, Lear continues to pay dividends. At its current share price of $110.17, the annualized dividend of $3.08 per share translates to a yield of 2.80%. This figure provides a baseline for income-focused investors.

Bullish investors might see the recent decline as a chance to buy. The RSI reading of 26.8 could suggest that the heavy selling is nearing an end. A chart of Lear’s dividend history can help determine the sustainability of the current payout.

The balance check

RSI: 26.8, Dividend yield: 2.80%, Lowest share price: $103.12

Based on reporting by Nasdaq, compiled by the Tradingbird newsroom. Published 06 Aug 2026, 22:04.
Topics: Stocks

Related

Warner Bros. Paramount merger trial pushed to March · Markets ·

Alphabet earns $112B, but most came from SpaceX gains · Markets ·

AstraZeneca's $133bn BMS talks fizzle · Markets ·

Consumer companies delaying IPOs as public market cools · Markets ·

UWM shares drop 35% after dividend halt and capital raise · Markets ·

Read this in: English · Arabiy · Deutsch · Espanol · Italiano · Portugues · Russkij · Turkce